Mark Stead

Mark Stead, PhD, is a seasoned biotech leader currently serving as Executive Director of Business Development at Amgen, where they enable partnerships and collaborations with technology innovators. With a strong background in molecular biology, Mark has held roles such as Senior Scientist and Senior Manager at Amgen, and Director of Alliance Management at Kite Pharma. Mark also worked as Senior Business Development Director at Exelixis, negotiating strategic transactions to advance cancer treatments. They further hold a PhD in Genetics from The University of Georgia and a B.S. in Biology from Saint Martin's University.